The Journal of Urology Vol. 203 (2020): January

Most Comprehensive and Affordable Self-study CME Product!

Make the most of yourJournal of Urology® Subscription

Developed by a team of educators, academicians, and clinicians, this valuable home study activity will enhance your knowledge of urology and improve performance as well as patient care at your convenience. For just $2.50 per credit, the Home Study program is designed to provide urologists and residents affordable access to the most recent developments and techniques in urology while readingThe Journal®.

Each month includes 5 clinically-relevant, selected articles with a corresponding online test for each of the 12 issues ofThe Journal®.

The American Urological Association designates this enduring material for a maximum of 24AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This Home Study Course is available only to subscribers ofThe Journal of Urology® and includes volumes 203 and 204.

The 2020 posttests will be posted online as they become available each month.

Target Audience

  • Practicing Urologists
  • American Board of Urology (ABU) candidates
  • Residents

Learning Objectives

After completing each lesson, the participants should be able to:

  1. Assess their knowledge of urology
  2. Demonstrate an increased knowledge base of urology
  3. Apply the increased knowledge to improve quality of patient care
Course summary
Available credit:
  • 2.00AMA PRA Category 1 Credit™
  • 2.00Non-Physician Participation
Course opens:
01/01/2020
Course expires:
01/31/2023
Rating:
0

Disclosures

(Individuals in control of the content. All individuals with their respective disclosures listed in this document are planners. Individual authors’ disclosures are located with their articles in each issue ofThe Journal of Urology®.)

Planner Disclosures

Victor Nitti, MD: Astellas: Health Publishing, Scientific Study or Trial; Allergan: Health Publishing, Scientific Study or Trial; Serenity Pharmeuticals: Investment Interest; Cook Myosite: Scientific Study or Trial
Brant Inman, MD, MS: Dendreon: Scientific Study or Trial; Abbott Laboratories: Scientific Study or Trial; Genentech, Inc.: Scientific Study or Trial; Combat Medical: Consultant or Advisor; FKD Therapies: Scientific Study or Trial; AstraZeneca: Consultant or Advisor; Taris Biomedical: Consultant or Advisor

The Journal of Urology® Editorial Board

Name Company Role
Anthony Atala MD Plureon Inc Leadership Position
Duane D. Baldwin ,MD Cook Urological, Inc. Meeting Participant or Lecturer
Olympus Corporation Consultant or Advisor
Bard Medical Divison Consultant or Advisor
DARRT Leadership Position
StepLite Leadership Position
Pfizer Investment Interest
Daniel Ari Barocas, MD Astra Zeneca Meeting Participant or Lecturer
Tolmar Consultant or Advisor
Peter Colin Black, MD GenomeDx Biosciences Inc Consultant or Advisor, Scientific Study or Trial
Janssen Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial
Astellas Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial
Amgen Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial
Sitka Consultant or Advisor
AbbVie Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial
Biosyent Consultant or Advisor
Bristol Myers Squibb Consultant or Advisor
PLOS ONE Health Publishing
BMC Urology Health Publishing
Merck Consultant or Advisor
iProgen Scientific Study or Trial
Bayer Consultant or Advisor
New B Innovation Scientific Study or Trial
RedLeaf Medical Meeting Participant or Lecturer
Biocancell Consultant or Advisor
Roche/Genentech Consultant or Advisor, Scientific Study or Trial
World Journal of Urology Health Publishing
Urologic Oncology Health Publishing
Bladder Cancer Health Publishing
Robert Edward Brannigan, MD The American Society for Reproductive Medicine (ASRM) Leadership Position, Health Publishing
The American Society for Reproductive Medicine Leadership Position
The National Institutes of Health Other
Rodney Henry Breau MD Nothing to disclose
Mark Patrick Cain MD Nothing to disclose
Toby C. Chai, MD Nothing to disclose
Craig Vance Comiter ,MD zenflow Scientific Study or Trial
Avails medical Consultant or Advisor
Neuspera Consultant or Advisor
BE technologies Scientific Study or Trial
Siamak Daneshmand, MD Photocure Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial
Taris Consultant or Advisor
Pacific Edge Consultant or Advisor
Ithaar H. Derweesh, MD GlaxoSmithKline, Inc. Scientific Study or Trial
Pfizer, Inc. Scientific Study or Trial
Scott E. Eggener ,MD NxThera Consultant or Advisor
Profound Medical Consultant or Advisor
Genomic Health Consultant or Advisor, Scientific Study or Trial
MDx Health Consultant or Advisor, Meeting Participant or Lecturer
Opko Health Consultant or Advisor, Scientific Study or Trial
Brian Howard Eisner, MD Ravine Group Owner, Product Development
Gyrus/ACMI/Olympus Consultant or Advisor
Boston Scientific Consultant or Advisor
Bard Consultant or Advisor
Retrophin Consultant or Advisor
Allena Consultant or Advisor
Kalera Medical Consultant or Advisor
Howard B. Goldman, MD allergan Consultant or Advisor
Medtronic Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial
Cook Scientific Study or Trial
Nuvectra Consultant or Advisor
Axonics Consultant or Advisor
NewUro Consultant or Advisor
Jason C. Hedges ,MD, PhD Nothing to disclose
Wayne John G. Hellstrom, MD Endo Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial
Theralogix Leadership Position
Coloplast Consultant or Advisor, Meeting Participant or Lecturer
NIH Leadership Position
New England Research Institutes, Inc Other
Abbvie Consultant or Advisor
Pfizer Consultant or Advisor
Allergan Consultant or Advisor
Boston Scientific Consultant or Advisor
Virility Consultant or Advisor
Ashish M. Kamat, MD FKD Scientific Study or Trial
Photocure Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial
Sanofi Consultant or Advisor, Meeting Participant or Lecturer
Abbott Molecular Consultant or Advisor
Theralase Consultant or Advisor
Telesta Therapeutics Inc. (formerly Bioniche) Consultant or Advisor
Heat Biologics Consultant or Advisor, Scientific Study or Trial
Pacific Edge, Ltd Meeting Participant or Lecturer
Merck Consultant or Advisor, Scientific Study or Trial
Spectrum Pharmaceuticals Consultant or Advisor
Oncogenix Consultant or Advisor
Cepheid Consultant or Advisor
Melissa Rae Kaufman MD Boston Scientific Consultant or Advisor, Other
Cook Myosite Other
Simon Kim, MD Nothing to disclose
Laurence H. Klotz, MD Ferring Consultant or Advisor, Scientific Study or Trial
Amgen Consultant or Advisor, Scientific Study or Trial
Astellas Meeting Participant or Lecturer, Scientific Study or Trial
Medivation Meeting Participant or Lecturer, Scientific Study or Trial
Abbvie Meeting Participant or Lecturer, Scientific Study or Trial
Janssen Meeting Participant or Lecturer, Scientific Study or Trial
Profound Medical Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial
Badrinath R. Konety, MD, MBA Photocure Inc Scientific Study or Trial
Genomic Health Scientific Study or Trial
NxThera Inc Consultant or Advisor
MDX Health Consultant or Advisor
Genentech/Roche Scientific Study or Trial
FKD Therapeutics Scientific Study or Trial
Jaime Landman, MD Cook Urological Consultant or Advisor, Owner, Product Development
Galil Medical Consultant or Advisor
CONMED Consultant or Advisor
Auris Consultant or Advisor, Investment Interest
Allergan Scientific Study or Trial
Gary Evan Lemack ,MD Allergan Consultant or Advisor, Meeting Participant or Lecturer
Roivant Consultant or Advisor
Yair Lotan ,MD abbott Scientific Study or Trial
Cepheid Consultant or Advisor, Scientific Study or Trial
Pacific Edge Scientific Study or Trial
FKD Scientific Study or Trial
MDxHealth Consultant or Advisor, Scientific Study or Trial
biocancell Scientific Study or Trial
Genomic Health Scientific Study or Trial
GenomeDx Biosciences Inc Scientific Study or Trial
photocure Consultant or Advisor, Scientific Study or Trial
William Thomas Lowrance, MD Myriad Genetics Scientific Study or Trial
Genome Dx Scientific Study or Trial
Argos Scientific Study or Trial
Stream Dx Investment Interest
Kevin Thomas McVary, MD, FACS Astellas Scientific Study or Trial
Lilly/ICOS Consultant or Advisor, Scientific Study or Trial, Other
NIDDK Scientific Study or Trial
AMS/Boston Scientific Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial
NeoTract Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial
Astellas Scientific Study or Trial
Sophiris Scientific Study or Trial
Merck Consultant or Advisor
Maxwell V. Meng AUA Health Publishing
Urologic Oncology (Journal) Health Publishing
大卫·克里斯托弗·米勒,医学博士,公共卫生硕士 Blue Cross Blue Shield of Michigan Other
National Cancer Institute Scientific Study or Trial
Nicole Lara Miller ,MD Boston Scientific Corporation Consultant or Advisor, Meeting Participant or Lecturer
Practical Reviews In Urology Health Publishing
Joel Byron Nelson MD Nothing to disclose
John Luther Phillips, MD Nothing to disclose
Mrs.. Deborah F. Polly Nothing to disclose
Sanoj Punnen, MD Genome Dx Meeting Participant or Lecturer
OPKO Diagnostics Scientific Study or Trial
Jay D. Raman, MD American Kidney Stone Management Investment Interest
Pacific Edge Biotechnology Consultant or Advisor, Scientific Study or Trial
Bradley Fields Schwartz ,MD Cook Medical Meeting Participant or Lecturer
Ojas Shah, M.D. Boston Scientific Consultant or Advisor, Meeting Participant or Lecturer
Elsevier Health Publishing
世界杯英格兰vs伊朗波胆预测 Meeting Participant or Lecturer, Other
Bristol Myers Squibb Investment Interest
Retrophin Consultant or Advisor
Applaud Medical Consultant or Advisor
NJ Kidney Stone Center Investment Interest
Glaxo Smith Kline Investment Interest
Novartis Investment Interest
Joseph A. Smith Jr.,MD Nothing to disclose
Kevan A. Sternberg ,MD The Journal of Urology Leadership Position
John T. Stoffel MD Uroplasty Scientific Study or Trial
PCORI Scientific Study or Trial
Journal of urology Leadership Position
Department of Defense Scientific Study or Trial
Ipsen Scientific Study or Trial
Ramakrishna Venkatesh Nothing to disclose
Julian Hsin-Cheng Wan MD Allergan Scientific Study or Trial
Journal of Urology Health Publishing

Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation: The American Urological Association designates this enduring material for a maximum of 24.0AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Learners:AUA没有资格向非MDs或DOs的参与者提供学分。However, the AUA will issue documentation of participation that states that the activity was certified forAMA PRA Category 1 Credit™.

AUA Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) participating in an educational activity provided by the AUA are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Resolution of Identified Conflict of Interest: All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/ or Education Conflict of Interest Review Committee or its subgroup
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point- counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty


Evidence-based Content:It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

Off label or Unapproved Use of Drugs or Devices: It is the policy of the AUA to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by faculty, authors, and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.

Release Date:January 2020.
Expiration Date:January 2023.

Copyright © 2020 by AMERICAN UROLOGICAL ASSOCIATION EDUCATION AND RESEARCH, INC.

Available Credit

  • 2.00AMA PRA Category 1 Credit™
  • 2.00Non-Physician Participation
Pleaseloginorregisterto take this course.